Latest for Common Variable Immunodeficiency
See all trialsThe week in rare diseaseEach date is the day a change was posted. Open an item to see where things stand now.
- Who can joinWho can join changed for Natural History of BronchiectasisClinicalTrials.gov
More about Common Variable Immunodeficiency
Common variable immunodeficiency (CVID) is a primary immunodeficiency disorder characterized by low IgG, from severely reduced to just below the normal adult range, with low IgA, IgM or both, combined with impaired specific antibody responses to vaccines and pathogens.
Keep reading about Common Variable Immunodeficiency
The underlying defect involves B cell differentiation and/or inadequate T cell help for B cells, with significant genetic heterogeneity accounting for variable presentations across affected individuals. Pathophysiologically, defects in genes regulating B cell development (TNFRSF13B, PIK3CD, CD19, ICOS, LRBA, and others) impair the ability to generate antibodies effectively.
Recurrent bacterial infections can begin in childhood or adulthood, predominantly affecting sinuses, ears, and respiratory tract (upper and lower). Recurrent gastrointestinal infections with Giardia, other parasites, or bacteria occur frequently. Progressive bronchiectasis develops from recurrent lung infections, significantly impacting pulmonary function and quality of life.
Many patients develop autoimmune manifestations including cytopenias (autoimmune hemolytic anemia, thrombocytopenia), autoimmune gastritis, pernicious anemia, and inflammatory bowel disease with prevalence of 20-30% in CVID populations. Increased rates of malignancies, particularly lymphomas and gastric adenocarcinoma, occur at higher rates than general population. Some patients develop granulomatous complications with granuloma formation in lungs, lymph nodes, or GI tract.
What are the symptoms of Common Variable Immunodeficiency?
These are common symptoms of Common Variable Immunodeficiency, and how strong they are varies from person to person.
- Recurrent bacterial infections of respiratory tract
- Recurrent gastrointestinal infections and diarrhea
- Sinusitis and otitis media
- Bronchiectasis development
- Autoimmune manifestations
- Increased malignancy risk
Who gets Common Variable Immunodeficiency?
Symptoms can begin anytime from childhood to adulthood, and most people are diagnosed in their 20s or 30s, according to MedlinePlus Genetics. It affects males and females equally. Most cases are sporadic, in people with no family history, and a known genetic cause is found in about 10% of cases, according to MedlinePlus Genetics.
Next steps: find trials you might fitsee approved treatmentsget help payingget alerts
Which medicines are FDA-approved for Common Variable Immunodeficiency?
There is currently 1 FDA-approved medication for Common Variable Immunodeficiency.
Source: openFDA drug labeling data. This list may not include all treatments. Always consult your doctor.
How to get help paying for Common Variable Immunodeficiency treatment
Charity funds and drugmaker programs for Common Variable Immunodeficiency, checked at the source.
- From a charity · The Assistance FundPrimary Immunodeficiency fundWaitlist
Pays for: Copays, coinsurance, deductibles and other health-related expenses.
Side effects people have reported to the FDA
Side effects people have reported to the FDA
Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.
Loading side effect data...
Diagnosis and genetic testing
Genetic testing for Common Variable Immunodeficiency
Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.
Finding labs...
Trusted Common Variable Immunodeficiency resources
Reputable organizations and medical references for learning more about Common Variable Immunodeficiency, including disease registries, foundation resources, and clinical guidelines.